This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Quinagolide

Authoring team

Quinagolide is a non-ergot D2 dopamine receptor agonist which may be used to treat hyperprolactinaemia.

Quinagolide is as effective as bromocriptine in reducing prolactin levels and is as well tolerated as once-daily bromocriptine.

Quinagolide is more expensive than the other dopamine receptor agonists and is probably worth considering only in patients resistant to bromocriptine and cabergoline).

It is not licensed for the suppression of lactation.

Note - treatment with dopamine-receptor agonists is associated with impulse control disorders, including pathological gambling, binge eating, and hypersexuality. Patients and their carers should be informed about the risk of impulse control disorders.

Reference

  1. NICE: BNF: Quinagolide. (Online, 2026)

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.